Sarah Hilgenberg

Clinical Instructor, Pediatrics

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (2010)

Residency: University of Washington Childrens Hospital and Regional Medical Center (2010) WA

Medical Education: Stanford University School of Medicine (2007) CA

Honors & Awards

Advancing Pediatric Educator eXcellence Teaching Program Scholar, American Academy of Pediatrics (2014-2016)

Rathmann Clinician Research Scholar in Medical Education, Stanford University (2014-2015)

ROSE Award for recognition of service excellence, LPCH (2012)

Administrative Appointments

Associate Program Director of Curriculum, Pediatric Residency Program (2013 - Present)

Physician Lead, Patient Experience, LPCH (2013 - Present)

“Recipient of a finding incidental to research”
Hilgenberg, S. (2013). “Recipient of a finding incidental to research”. Presented at the Incidental Findings in Research, Presidential Commission for the Study of Bioethical Issues, http://bioethics.gov/node/1617.

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)
Qureshi, M. M., Hayden, D., Urbinelli, L., Ferrante, K., Newhall, K., & Cudkowicz, M. E. (2006). Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). AMYOTROPHIC LATERAL SCLEROSIS, 7(3), 173-182.

Transformation: from medical student to patient.
Hilgenberg, S. (2006). Transformation: from medical student to patient. Annals of internal medicine, 144(10), 779-780.

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease
Lorenzl, S., Albers, D. S., Relkin, N., Ngyuen, T., Hilgenberg, S. L., & Beal, M. F. (2003). Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. NEUROCHEMISTRY INTERNATIONAL, 43(3), 191-196.

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
Lorenzl, S., Albers, D. S., LeWitt, P. A., Chirichigno, J. W., Hilgenberg, S. L., & Beal, M. F. (2003). Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. JOURNAL OF THE NEUROLOGICAL SCIENCES, 207(1-2), 71-76.